It is noteworthy that recent studies indicated that syncytin-1 expression is activated and upregulated in a variety of malignancies including breast cancer [16, 25], endometrial carcinomas [17, 18, 26], ovarian cancer [27], colorectal cancer [19], leukemia and lymphoma [28]. Here, ERVW-1 is linked to endometrial carcinoma.